SCHEMBL29429438

CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O

nearest known ligand 0.81

Predicted protein targets (top 5)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	18/20	0.81

▸	GCGR	P47871	9/20	0.81

▸	GIPR	P48546	6/20	0.80

▸	CCKBR	P32239	4/20	0.70

▸	KEAP1	Q14145	1/20	0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
Exenatide SCHEMBL20509814	0.99	GLP1R (0.81)	GLP1RGCGRGIPRCCKBRKEAP1
Exenatide SCHEMBL29827241	0.99	GLP1R (0.81)	GLP1RGCGRGIPRCCKBRKEAP1
Exenatide SCHEMBL29710890	0.99	GLP1R (0.81)	GLP1RGCGRGIPRCCKBRKEAP1
SCHEMBL29429437	0.99	GLP1R (0.81)	GLP1RGCGRGIPRCCKBRKEAP1
Exenatide SCHEMBL14634818	0.99	GLP1R (0.81)	GLP1RGCGRGIPRCCKBRKEAP1
SCHEMBL31072728	0.99	GLP1R (0.81)	GLP1RGCGRGIPRCCKBRKEAP1
Exenatide SCHEMBL28285812	0.99	GLP1R (0.82)	GLP1RGCGRGIPRCCKBRKEAP1
Exenatide SCHEMBL28323280	0.99	GLP1R (0.81)	GLP1RGCGRGIPRCCKBRKEAP1
Exenatide SCHEMBL29503493	0.99	GLP1R (0.80)	GLP1RGCGRGIPRCCKBRKEAP1
SCHEMBL29357267	0.98	GLP1R (0.81)	GLP1RGCGRGIPRCCKBRKEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-2506896-B1	DEVICE AND METHOD FOR DELIVERY OF TWO OR MORE DRUG AGENTS	SANOFI AVENTIS DEUTSCHLAND (DE)	2025-04-09	—	—	EP	disclosed
US-20230303640-A1	EXENDIN-4 PEPTIDE ANALOGS	TXP PHARMA AG (CH)	2023-09-28	—	—	US	disclosed
US-20230270941-A1	DRUG DELIVERY DEVICE AND METHOD OF OPERATION	SANOFI-AVENTIS DEUTSCHLAND GMBH (DE)	2023-08-31	—	—	US	disclosed
US-20230113413-A1	POLYMER DERIVATIVES HAVING PARTICULAR ATOM ARRANGEMENTS	NEKTAR THERAPEUTICS (US)	2023-04-13	—	—	US	disclosed
US-11446385-B2	Polymer derivatives having particular atom arrangements	NEKTAR THERAPEUTICS (US)	2022-09-20	—	—	US	disclosed
US-11267861-B2	Peptide-oligourea foldamer compounds and methods of their use	UREKA SARL (FR)	2022-03-08	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-11446385-B2	Polymer derivatives having particular atom arrangements	CD44, PIGO, PGLS	GLP1R 4435/4885GCGR 4180/4885GIPR 2378/4885
US-11267861-B2	Peptide-oligourea foldamer compounds and methods of their use	IAPP, OTC, OAT	GLP1R 121/4885GCGR 1875/4885GIPR 158/4885
US-20230113413-A1	POLYMER DERIVATIVES HAVING PARTICULAR ATOM ARRANGEMENTS	CD44, PIGO, PGLS	GLP1R 4435/4885GCGR 4180/4885GIPR 2378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.